Comparing the efficacy and safety of nafamostat mesylate versus citrate for anticoagulation in continuous renal replacement therapy: a systematic review and meta-analysis

BackgroundAnticoagulation is pivotal to the successful implementation of continuous renal replacement therapy (CRRT). Systematic comparative studies between nafamostat mesylate (NM) and citrate are scarce. There is currently a lack of evidence-based support for clinical practice.ObjectiveTo systemat...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Zhao Hua Zou, Ji Quan Zhang, Pei Jun Xiang, Xing Chen, Wei Qing
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2026-07-01
Reeks:	Frontiers in Medicine
Onderwerpen:	anticoagulation citrate continuous renal replacement therapy meta-analysis nafamostat mesylate
Online toegang:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1831023/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!